Cerdelga
Active substance: eliglustat
CAPSULE · ELIGLUSTAT 84 mg/1
United StatesActive
Marketing holder: Genzyme Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ELIGLUSTAT · 84 mg/1
Analogues by country
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c4-b7ec-753a-9a87-c1ab627e928d;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-8621-7908-bde5-2019863490cb;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 58468-0220
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 58468-0220 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58468-0220 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58468-0220 · Verified 2026-10-09 · open in source